e.g. Tata motors, Reliance MF, 500570

Kappac Pharma Ltd. - Research Center

506938 KAPPH Group (XC) BSE data
 
Back to Company Page
Statement:

Balance sheet

(Rs crore)
Mar ' 20 Mar ' 18 Mar ' 17 Mar ' 16 Mar ' 15
Sources of funds
Owner's fund
Equity share capital 30.27 30.27 30.27 30.27 30.27
Share application money - - - - -
Preference share capital - - - - -
Reserves & surplus 6.03 7.69 7.70 7.74 7.77
Loan funds
Secured loans - 0.20 - - -
Unsecured loans - - - - -
Total 36.29 38.16 37.96 38.01 38.03
Uses of funds
Fixed assets
Gross block - - - - -
Less : revaluation reserve - - - - -
Less : accumulated depreciation - - - - -
Net block - - - - -
Capital work-in-progress - - - - -
Investments 11.46 37.99 37.99 38.01 38.01
Net current assets
Current assets, loans & advances 24.89 0.22 0.02 0.03 0.03
Less : current liabilities & provisions 0.06 0.05 0.05 0.03 0.01
Total net current assets 24.83 0.17 -0.03 - 0.02
Miscellaneous expenses not written - - - - -
Total 36.29 38.16 37.96 38.01 38.03
Notes:
Book value of unquoted investments - - 29.31 29.31 29.70
Market value of quoted investments - - - - -
Contingent liabilities - - - - -
Number of equity sharesoutstanding (Lacs) 302.65 302.65 302.65 302.65 302.65
Close
Add Kappac Pharma Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Kappac Pharma Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close

Home

Market News

Latest News

International Markets

Economy

Industries

Mutual Fund News

IPO News

Search News

My Portfolio

My Watchlist

Gainers

Losers

Sectors

Indices

Forex

Mutual Funds

Feedback